We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Resigned to Trials to Show Biosimilar Interchangeability
Sponsors Resigned to Trials to Show Biosimilar Interchangeability
September 21, 2012
The FDA appears poised to require clinical trial data from drugmakers seeking biosimilar interchangeability designations, a move that could shrink the number of products that aim to achieve the standard, drugmakers and legal experts say.